Article
Exceptional response to pembrolizumab in HER2-positive gallbladder carcinoma with high tumor mutational burden
2024-09-09
Abstract excerpt
<title>Abstract</title> <p>Patients with advanced cholangiocarcinoma, including gallbladder cancer, typically have a poor prognosis owing to limited effective chemotherapy options. The field of genotype-directed therapy in patients with cholangiocarcinoma is advancing. However, limited clinical data are currently available to evaluate the efficacy of molecularly targeted therapy. Herein, we report the case of a 6...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7401a3d3-5a42-59ac-811e-9f9245393ce9
- DOI
- 10.21203/rs.3.rs-4855823/v1